An Australian Medical Cannabis Company Just Sold Its First Pot Pills

September 2, 2015

Australian medical cannabis company MMJ PhytoTech Limited has just sold its first marijuana pills. The bad news: They are only available in Europe.

The capsules were sold in August via a Swiss-based subsidiary, Satipharm. 10 milligrams of the medication will set you back 89 euros (A$139.95).

The pills are registered as a dietary supplement in Germany. Their active ingredient, Cannabidiol (CBD), is made from a special medical cannabis strain and they do not contain tetrahydrocannabinol (THC), the chemical that causes most of marijuana's psychological effects when smoked.

Viola, Tempter’s Unite to Elevate the Cannabis Beverage Experience

Blüm Holdings Signs $5M Agreement to Acquire Northern California Cannabis Dispensary

FLUENT Appoints Former Governor to Board of Directors

Cannabist Cultivation Workers Ratify 1st Union Contract in New Jersey

Viola, Tempter’s Unite to Elevate the Cannabis Beverage Experience

The multi-national cannabis brand is partnering with the pioneering hemp-derived THC beverage company.

Cs Viola Mockup

Blüm Holdings Signs $5M Agreement to Acquire Northern California Cannabis Dispensary

The new dispensary will join Blüm’s growing portfolio, which includes three other Northern California stores and a recently acquired Bay Area location.

Blum Holdings

FLUENT Appoints Former Governor to Board of Directors

Peter Shumlin, a Democrat who served three terms as Vermont’s governor, joins the cannabis company’s board.

Cannabist Cultivation Workers Ratify 1st Union Contract in New Jersey

The cannabis workers in Vineland voted to accept their contract with UFCW Local 152 after first deciding to organize nearly three years ago.

Local152

Cronos Grows International Footprint in Switzerland

The Canadian cannabis company partnered with Dascoli Pharma AG to expand the distribution of its PEACE NATURALS brand in the Swiss market.

AYR Wellness Misses Interest Payment on Outstanding Senior Notes

The cannabis company does not anticipate that the missed payment will result in operational challenges as it restructures its debt profile.

Ayrlogoresized2

TerrAscend Exiting Michigan, Will Sell 4 Cultivation Facilities, 20 Dispensaries

The cannabis company announced the strategic exit to focus on core markets. The net proceeds from its divestitures will be used to pay down debt.

California Cannabis Excise Tax Hike Takes Effect as Consumers Face Mounting Cost-of-Living Crisis

The excise tax increase will drive more Californians to the unlicensed market; Assembly Bill 564 offers a path to roll back the policy.

Money Mj 371005338

4Front Ventures’ Receivership Proceedings Progress; Board Members Resign

Board Chairman Kris Kane and Director David Daily resigned as a result of a receiver appointment under Canada’s Bankruptcy and Insolvency Act.

AYR Wellness Has No Estimate for Q1 2025 Interim Filings; Trading Remains on Hold

The cannabis company’s delay in filing its financial statements comes as its negotiations with creditors remain ongoing.

Ayrlogoresized2

Aurora Expands Patient Access to Medical Cannabis in Canada With Extended Compassionate Pricing Program

The Canadian cannabis company expanded its eligibility of the program to those with an annual income of up to 60,000 CAD.

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

Page 1 of 656